BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20128980)

  • 1. [A brief report on the third national congress of fatty liver disease and summit forum of Hong Kong, Taiwan and mainland China].
    Wang BY; Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):73-4. PubMed ID: 20128980
    [No Abstract]   [Full Text] [Related]  

  • 2. [A brief report from the 1st China Viral Hepatitis and Fatty Liver Summit].
    Fan JG; Zhang DZ; Yuan PG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):714. PubMed ID: 19785969
    [No Abstract]   [Full Text] [Related]  

  • 3. Alcoholic and nonalcoholic forms of fatty liver disease.
    Forgione A; Miele L; Cefalo C; Gasbarrini G; Grieco A
    Minerva Gastroenterol Dietol; 2007 Mar; 53(1):83-100. PubMed ID: 17415346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictive factors for pure steatosis in alcoholic patients.
    Naveau S; Thaury J; Barri-Ova N; Balian A; Dauvois B; Njiké-Nakseu M; Prévot S; Agostini H; Perlemuter G
    Alcohol Clin Exp Res; 2009 Jun; 33(6):1104-10. PubMed ID: 19382900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of alcoholic and nonalcoholic fatty liver disease in China.
    Fan JG
    J Gastroenterol Hepatol; 2013 Aug; 28 Suppl 1():11-7. PubMed ID: 23855290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of non-alcoholic fatty liver disease in China.
    Fan JG; Farrell GC
    J Hepatol; 2009 Jan; 50(1):204-10. PubMed ID: 19014878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-alcoholic fatty liver--life of overindulgence with fatty liver].
    Füessl HS
    MMW Fortschr Med; 2005 Jun; 147(25):4-6, 8. PubMed ID: 16038330
    [No Abstract]   [Full Text] [Related]  

  • 8. Scientific publications in anesthesiology journals from mainland China, Taiwan, and Hong Kong: a 10-year survey of the literature.
    Li Z; Shi J; Liao Z; Wu FX; Yang LQ; Yu WF
    Anesth Analg; 2010 Mar; 110(3):918-21. PubMed ID: 19955511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Liver damage in alcoholics].
    Laskus T; Lupa E; Slusarczyk J
    Postepy Hig Med Dosw; 1991; 45(6):509-26. PubMed ID: 1813885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Strengthen the management of chronic viral hepatitis patients with fatty liver].
    Fan JG
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):801-3. PubMed ID: 19958634
    [No Abstract]   [Full Text] [Related]  

  • 11. [A brief report on the 5th National Congress of Fatty Liver Disease and 2013 Frontiers Medical Forum in China].
    Cao HX; Fan JG; Shi JP; Li YM; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):799-800. PubMed ID: 24579237
    [No Abstract]   [Full Text] [Related]  

  • 12. Scientific publications in laboratory medicine from mainland China, Hong Kong and Taiwan: A ten-year survey of the literature.
    Liu DH; Cui W; Yao YT; Jiang QQ
    Clin Chim Acta; 2010 Oct; 411(19-20):1502-5. PubMed ID: 20599867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A brief report on the fourth national congress of fatty liver disease].
    Duan XY; Fan JG; Chen DF; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2011 Sep; 19(9):711-2. PubMed ID: 22152393
    [No Abstract]   [Full Text] [Related]  

  • 14. Fatty liver--current look at the old disease.
    Mach T
    Med Sci Monit; 2000; 6(1):209-16. PubMed ID: 11208312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's disease-induced non-alcoholic fatty liver disease (NAFLD) sensitizes for severe acute hepatitis B infection and liver failure.
    Canbay A; Bechmann LP; Best J; Jochum C; Treichel U; Gerken G
    Z Gastroenterol; 2006 Mar; 44(3):245-8. PubMed ID: 16514570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Tarantino G; Saldalamacchia G; Conca P; Arena A
    J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease.
    Schaffner F; Thaler H
    Prog Liver Dis; 1986; 8():283-98. PubMed ID: 3086934
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolic syndrome and NASH.
    Marchesini G; Marzocchi R
    Clin Liver Dis; 2007 Feb; 11(1):105-17, ix. PubMed ID: 17544974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Weight loss: cornerstone in the treatment of non-alcoholic fatty liver disease.
    Tilg H; Moschen A
    Minerva Gastroenterol Dietol; 2010 Jun; 56(2):159-67. PubMed ID: 20485253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and histological features of non-alcoholic fatty liver disease in Hong Kong Chinese.
    Wong VW; Chan HL; Hui AY; Chan KF; Liew CT; Chan FK; Sung JJ
    Aliment Pharmacol Ther; 2004 Jul; 20(1):45-9. PubMed ID: 15225170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.